Yes you are right ..... big names & big players , with huge...

Yes you are right ..... big names & big players , with huge budgets and huge market caps .

Plenty of info out there ...

Sure many of these companies have been around for a long time & have multi product portfolios .

but IMC has a market cap , which is sort of "petty cash " by comparison with some of their associates playing on the same filed .

I dont think its "IF " - but more likely "WHEN" ......... one of these big players is going to want to collaborate / JV / buy into some of the stuff they are doing .

Assuming IMC has the goods .... ( and it seems like they do ) in a number of fields ..... its not hard to see some huge potential upside .

Patience , patience , patience

Ignore the red & get back to bed , dont let the share price mess with your head !!!

Lol

	Type
1	Public limited company
2	Traded as	LSE: GSKNYSE: GSKFTSE 100 Component
3	Industry	PharmaceuticalBiotechnologyConsumer goods
4	Predecessor	Glaxo plcWellcome plcBeecham Group plcSmith Kline & French Inc
5	Founded	December 2000; 17 years ago
6	Headquarters	980 Great West Rd, Brentford,London, United Kingdom
7	Area served
8	Worldwide
9	Key people
10	Sir Philip Hampton(Chairman) Emma Walmsley(CEO)
11	Products	Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines
12	Revenue	£30.186 billion (2017)[1]
13	Operating income
14	£4.087 billion (2017)[1]
15	Net income
16	£2.169 billion (2017)[1]
17	Number of employees
18	99,300 (2016)[2]
19	Subsidiaries	Stiefel Laboratories
20	Website	www.gsk.com

For instance
Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317-276-2000
http://www.lilly.com
Sector: Healthcare
Industry: Drug Manufacturers - Major
Full-time employees: 40,655